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Highlights 
 Charging of pharmaceutical inhalation powders depends on a combination of many 
interrelated factors. 
 Controlling the charge of inhalation powders is crucial in the development of dry powder 
inhaler products. 
 More controlled studies are justified to increase our understanding in charging. 
 Efforts to optimize the charge of drug and carrier particles to maximize DPI performance 
are warranted. 
 
 
Abstract 
Pharmaceutical powders are typically insulators consisting of relatively small particles and thus 
they usually exhibit significant electrostatic charging behaviours. In the inhalation field, the 
measurement of electrostatic charge is an imperative stage during pharmaceutical formulation 
development. The electrostatic charge is affected by the interplay of many factors. This article 
reviews the factors affecting the electrostatic charging of pharmaceutical powders with a focus 
on dry powder inhalations. The influences of particle resistivity, size distribution, shape 
distribution, surface roughness, polymorphic form and hygroscopicity, as well as the effects of 
moisture uptake, environmental conditions, pharmaceutical processing (i.e., milling, sieving, 
spray drying and blending), and storage on the electrostatic charge behaviours of 
pharmaceuticals, with focus on inhalation powders, were reviewed. The influence of 
electrostatic charge on the performance of dry powder inhaler formulations in terms of drug 
content homogeneity, the passage of drug through the inhaler device, drug–carrier 
adhesion/detachment, and drug deposition on the respiratory airways were discussed. The 
understanding gained is crucial to improving the safety, quality, and efficiency of the 
pharmaceutical inhalation products. 
3 
 
Abbreviations 
AFM, atomic force microscopy; BCMS, bipolar charge measurement system; BET, Brunauer, 
Emmett and Teller; BOLAR, bipolar charge analyser; CM, commercial mannitol; CMR, charge–
to–mass ratio; CSR, charge–to–surface ratio; d50%, median diameter; DPIs, dry powder inhalers; 
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velocimeter; MDIs, metered dose inhalers; nC/g, nano-coulomb/gram; RH, relative humidity; 
SDM, spray dried mannitol; SS, salbutamol sulphate. 
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1. Overview of electrostatic charge 
1.1. Charging mechanisms 
Electrostatic effects on solids have been recognised for a long time, yet our understanding 
remains limited due to its complexity. Several authors explained the fundamentals of 
electrification phenomenon and charging mechanisms (Chiou et al., 2003; Crofts, 1988; 
Gonsalves, 1953; Matsusaka, 2011; Matsusaka et al., 2010; Vick, 1953; Yatsuzuka et al., 1996). 
Although it is still indefinite whether charge-transfer takes place through electron, ion or material 
transfer, or a combination of these, charge-transfer has been mostly described based on electrons 
as the charge carriers (Cross, 1987; Harper, 1943; Lowell and Rose-Innes, 1980). In general, 
contact electrification or contact charging is the main mechanism of charge-transfer for solid 
particles. Contact charging is a phenomenon by which an electric charge transfers from one 
surface to another when two electrically–isolated surfaces are brought into contact and then 
separated (Taylor and Secker, 1994). Materials may subsequently gain a positive or negative 
netcharge that is usually a complex bipolar system (Bailey, 1993, 1984). Triboelectric 
charging or tribocharging within powders develops when the contact is accompanied with 
frictional forces such as sliding, rubbing, rolling or impaction in an unionised environment 
(Greason, 1992; Lowell and Rose-Innes, 1980; Trigwell et al., 2008). In pharmaceutical 
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processes tribocharging (‘frictional electrification’) refers to a method of particle 
electrification that occurs during unit operations (Matsusaka et al., 2010). Corona charging is a 
process by which a neutral particle is charged by exposing it to a single polarity of an ion or a 
charged particle that could be discharged in a bi-ionised field. Corona charging is usually 
favoured in many applications because of its reliability and high charge values. It is 
regularly used when there is a need to charge a surface in a defined way (Cross, 1987).  
2. Charging of powders in industrial handling 
Pharmaceutical solids are usually insulators and thus they are likely to carry an electrostatic 
charge during powder handling processes (Askal, 1997; El-Sadek et al., 1993; Khaled, 2008). In 
industrial handling processes with bulk solids, the materials are very likely to be charged and 
consequently the concept of an electrically neutral particle is scarcely true (Glor, 1988). Any 
handling of powders (regardless of their formulation and the types of the materials used for 
storage and processing) results in collisions among the individual particles with one another and 
with the walls of the process equipment. This, in turn, results in the accumulation of charge on 
the surfaces of these particles (Glover and Chan, 2004), as will be explained in chapter 3.1. In 
general, bulk powders could be triboelectrically charged by several ways, such as vibrating 
devices (Dascalescu et al., 2005), high-shear blenders (Eliasen et al., 1999), low-shear blenders 
(Engers et al., 2006), fluidised beds (Calin et al., 2007), rotary drums (Inculet et al., 1998), drying, 
and transport (Saleem et al., 2008). In contrast, several approaches have been applied to reduce 
the electrostatic charging, such as grounding of all parts of powder charge equipment 
(Kassebaum and Kocken, 1997), placing a ground probe in the processing equipment (Blythe and 
Reddish, 1979), the use of the radioactive ionization device (Kassebaum and Kocken, 1997), the 
use of a superimposed electric field (Ebadat et al., 1990), working under high environmental 
relative humidities (Cartwright et al., 1985), and the use of antistatic agents (Kassebaum and 
Kocken, 1997).  
3. Factors that affect electrostatic charging of pharmaceuticals 
The electrostatic charge could be found in powders having similar or dissimilar chemical 
composition(s). It has been acknowledged that the static electrification generated during powder 
handling operations is incompetently understood and hard to predict because of its inherent 
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multivariate nature (Rowley, 2001). In general, different powders might develop different 
polarities and levels of charge according to their inherent ‘intrinsic’ electrical properties 
(Chakrabarty et al., 2008; Valverde et al., 2008) and types/properties (e.g., surface area) of the 
surfaces they contact during different processing steps (Lachiver et al., 2006; Rowley, 2001). The 
generation and decay of electrostatic charge on the surface of charged particles also depend on 
their physicochemical properties, such as surface resistivity (Lachiver et al., 2006; Sharma et al., 
2001b), surface roughness (Eilbeck et al., 1999), surface impurities, size distribution, shape 
distribution (Carter et al., 1998), and molecular structure (Duke and Paton, 1981). The 
electrostatic charge is furthermore influenced by environmental conditions (e.g., the relative 
humidity (RH) and atmospheric pressure) (Rowley and Mackin, 2003), particle motions and 
binary collisions (Liao et al., 2011), and magnitude of the frictional forces (Pavey, 1998). The 
influence of some factors on the electrostatic charging of pharmaceuticals is discussed below 
(Figure 1). 
3.1. Work function 
Electron-transfer results from the contact of two contact points having different work 
functions. The work function is an intrinsic surface property defined as the minimum energy 
required to move the weakest bound electron from the surface of a solid to the vacuum energy 
level (Gallo and Lama, 1976). The direction of electron-transfer is expected to go from the 
material with a lower work function to that with a higher work function. The electron-transfer 
process continues until the Fermi level, which is the level where the probability of occupancy of 
states with electrons in the allowed energy state is, of two materials reaches equilibrium (Davies, 
1969). The following separation of these materials leads to the accumulation of charge on the 
surface of each material, such that they have an equal level of charge but opposite signs (Gallo 
and Lama, 1976). 
When two charged particles are brought into contact, they will experience attraction or repulsion 
depending on their electrical charge signs. Coulombic forces govern the magnitude of the 
electrostatic attraction/repulsion forces (Fel) between particles, as defined by Coulomb’s law (Eq. 
1) (in the simplest case of two-point charges) (Seville et al., 1997). 
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where q1 and q2 are the electrical charges on the two particles respectively, ε is the relative 
permittivity, ε0 is the permittivity of free space (given by 8.854 × 10-12 C2/Nm2), and d is the 
distance of separation between the two particles. 
If a charged particle encounters an uncharged particle, the first particle will induce an image 
charge on the surface of the second particle. The electrostatic force (Fc) between these particles is 
then calculated as follows. 
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where q is the electrical charge on the charged particle, r is the radius of the interacting particles, 
and d is the distance between the charged and uncharged particles. 
When two solid materials of different work functions are separated (in vacuum) by a small 
distance (d), electrons transfer from the material with the lower work function to the material 
with the higher one. Equilibrium will be established eventually, in which the two work functions 
reach the same level. The forces of attraction (Fw) between these two solid materials can then be 
determined using the following equation. 
 
2
W
ΔU
F =πεr
d
 (3) 
where (ΔU) is the potential difference arising from the difference in work functions between the 
two materials and r is the radius of the interacting particles. 
3.2. Physicochemical properties 
Drawing definite conclusions concerning the effects of one physicochemical property on 
electrostatic charge behaviour is difficult because of interactions among several variables related 
to the formulation parameters, dispersion conditions, and environmental conditions (Figure 1). 
Nevertheless, rational justifications for most of the observed effects are discussed below. 
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3.2.1. Resistivity 
Surface resistivity is related to the level of charge a material can pick up/lose upon contact with 
another surface. For materials with high surface resistivities, charge decay slowly and therefore 
such materials have high electrostatic effects. Substances could be broadly categorised into three 
classes based on their resistivity, i.e., conductors (resistivity below 1010 Ωm), semiconductors 
(resistivity from 1010 Ωm to 1013 Ωm) and insulators (resistivity above 1013 Ωm). The surface 
resistivity of a material is strongly dependent on the RH of the environment (LuKttgens and Glor, 
1989). The adsorption of water into a particle could contribute free charge carriers and/or 
influence the material’s carrier trapping characteristics. Thus, the resistivity of a material 
typically decreases with increasing the environmental humidity (Passi et al., 2001). 
3.2.2. Particle size distribution 
The effect of particle size and density on the electrical and nonelectrical charge-transfer 
efficiency was studied by several reports (Biehl and Barringer, 2004; Mayr and Barringer, 2006). 
It has been suggested that the energy required to transfer an electron between two insulating solid 
particles depends on particle size (Gallo and Lama, 1976; Schein, 1993). In this view, for 
particles of the same material, electrons are expected to transfer from large particles to smaller 
particles, because large particles have typically lower work functions than the smaller particles 
(Bailey, 1984). Therefore, large particles often charge opposite to smaller particles of the same 
material (Ali et al., 1998; Zhao et al., 2002). In general, for mixtures containing fine and coarse 
particles, fine particulates tend to charge negatively, whereas large particles tend to charge 
positively regardless of whether the netcharge is positive or negative (Ali et al., 1998; Engers 
et al., 2006; Glor, 1988; Trigwell et al., 2003). Although the precise reasons for this behaviour 
are not clear, a hypothetical mechanism for particle size dependent charging has been provided 
by (Lacks and Levandovsky, 2007). The physical explanation described is based on the 
arguments that collisions allow electrons trapped in high-energy states on one particle to 
transfer to the vacant low-energy states on another particle (assuming that the surface 
density of trapped electrons is initially the same on all particles).  
Electrostatic forces become more significant and may even dominate over other particulate forces 
(including van der Waals forces) when the particle size is decreased at low environmental 
humidities. Therefore, small particles usually tend to carry a greater level of netcharge-to-
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surface ratio (net‒CSR) than the larger particles, i.e., powder charge is inversely related to 
particle mean diameter (Guardiola et al., 1996; Kaialy et al., 2014; Rowley, 2001). For example, 
under similar fluidisation conditions, (Karner and Urbanetz, 2013) showed the amount of 
netcharge accumulated on mannitol powders to increase with the fine fraction of small mannitol. 
This agreed with previous studies carried out by (Carter et al., 1992), (Eilbeck et al., 2000, 1999) 
and (Kwek et al., 2012) who showed the netcharge of lactose to increase with decreasing particle 
size. This could be explained as the specific surface area (per unit mass) increases with 
decreasing particle diameter and this makes a higher netcharge-to-surface ratio (net-CSR) 
for smaller particles obvious. Nevertheless, it should be kept in mind that the exact mechanism 
by which particle size distribution affects the electrostatic charge behaviour is complicated by the 
number of factors directly related to particle size. A difference in the work function between 
small and large particles was suggested (Gallo and Lama, 1974; Zhao et al., 2003), although such 
difference is believed to be very small (<0.01 %) for particles larger than 1 µm (Wood, 1981). 
The differences in the surface properties (such as crystal lattice, rugosity, surface energy and 
surface area) among particles of different sizes could also account for the different work 
functions obtained (Figure 1). Large particles have been reported to show relatively higher 
surface roughness (Kaialy et al., 2012a; Narayan and Hancock, 2005), higher amount of surface 
impurities (Boer et al., 2003), greater shape-irregularities (cracks and dislocations) (Shariare et al., 
2011), decreased disorder in crystal lattice (Kaialy et al., 2012a; Pearce and Lewis, 1972) and 
lower moisture uptake (van Campen et al., 1983), as compared to smaller particles. In an 
endeavour to reduce as many of the linked parameters as possible, (Kaialy et al., 2014) evaluated 
the charging and aerosolisation properties of spherical spray dried mannitol (SDM) particles 
with identical shape and solid-state characteristics but of different sizes. The netcharge 
(netcharge-to-mass ratio (net‒CMR) or charge density) of SDM particles was shown to increase 
from (-0.1 ± 0.1) nC/g to (2.3 ± 0.8) nC/g with decreasing the mean size of SDM particles from 
122 µm to 45 µm (Figure 2). The authors attributed this effect to the higher particle–wall contacts 
(Rowley, 2001), the greater particle number density, and the higher specific surface (Zhu et al., 
2007) for smaller particles, providing a significant increase in the overall surface area available 
for charge-transfer. (Saini et al., 2007) showed the percentage number of neutral particles 
aerosolised from a dry powder inhaler (DPI) to increase with the mean particle size. However, 
the level and sign of the electrostatic charge acquired by the inhaled particles as well as the 
9 
 
particle size measurements of aerosolised particles are all influenced by the interplay of several 
factors including the formulation and inhaler material. Thus, more controlled work is required in 
the further to understand the effect of these factors on the charge and size measurements of 
inhaled particles. 
3.2.3. Particle shape distribution 
Particle shape is the recognised pattern of relationships among all the points forming the external 
particle surface (Luerkens et al., 1987). Particle shape is one of the most uncontrollable factors in 
powder technology. Different production techniques (e.g., nonsolvent precipitation, spray drying, 
etc.) for one material will practically continually lead to the production of particles of different 
shapes, and even particles that have experienced similar treatments may exhibit different shapes. 
Most pharmaceutical solid particles are diverged from the spherical shape (Hickey and Concessio, 
1997). Nevertheless, all equations that calculate the interparticle forces (either van der Waals, 
capillary or electrostatic forces) are built on the unrealistic situation, which assumes that particles 
of a predetermined shape interact under theoretical conditions (an interaction between perfect 
spheres with perfectly smoothed surfaces). Therefore, any effort to deduce an equation that 
accurately calculates the interparticle forces between the real irregular-shaped particles would 
prove to be unrealistic, although a qualitative assessment of the particulate interaction within a 
powdered system is possible using the simple principles generated from perfect situations.  
Particle shape distribution could have a significant effect on powder charging (Murtomaa et al., 
2004a). (Chakrabarty et al., 2008) argued that the possibility of a particle carrying a certain 
number of charges depends on its morphology, i.e., spherical particles are less prone to attain 
more charge than elongated particles of the same particle mass. The results agreed with our 
results, which compared the electrostatic charging of mannitol particles with a similar size 
range (63 μm to 90 μm) but two distinct morphologies (Kaialy et al., 2014). Spherical mannitol 
particles showed a considerably lower netcharge than irregular-shaped mannitol particles ((0.7 ± 
0.2) nC/g versus (3.7 ± 0.5) nC/g) (Figure 4). (Karner et al., 2014) also reported similar results 
for mannitol particles (d50%(median diameter): 78.4 µm to 86.4 µm), i.e., particles with more 
elongated shapes carried a higher level of charge than less elongated particles.  
Not only the amount of charge of individual particles differs considerably, but also the degree of 
nonuniformity of charge distribution on particle surface is likely to vary from particle to particle 
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due to the arbitrariness of tribocharging process. Thus, the concept of charge distribution on 
particle surface was proposed (Hays and Wayman, 1989). A uniform charge distribution on the 
surface of a spherical particle has been assumed in theoretical calculations due to the lack of 
information about detailed surface charge distributions (Feng and Hays, 2003). (Murtomaa et al., 
2004a) showed the reproducibility of electrostatic charging to improve with homogeneous 
particle morphology. For non-spherical particles, particle morphology and charge distribution on 
particle surface are important factors for unipolar diffusion charging (Biskos et al., 2004).  
3.2.4. Particle surface properties 
Since charging is a surface phenomenon, particle surface characteristics could have a significant 
influence on the charging behaviour of powders. Surface area is considered a measure of 
surface geometry, whereas surface free energy represents the amount of energy needed to 
separate particles or surfaces (Fowkes, 1964). Many factors could deeply affect particle surface 
area, including particle size, shape, anomeric form and surface morphology (Figure 1). In general, 
particles with smaller size distributions and more surface irregularities have higher surface 
areas (Lowell and Shields, 1991). Powders with higher specific surface areas usually show 
higher moisture uptakes (Van Campen et al., 1983) and higher surface free energies 
(Sethuraman and Hickey, 2002). In the literature, the surface properties of a particulate material 
were shown to affect the materials’ physical properties, such as its flowability (Han et al., 2011), 
cohesivity and adhesivity (Kaialy and Nokhodchi, 2013a). Additionally, several pharmaceutical 
processes, such as milling (Julien et al., 2011), blending (Rumondor et al., 2011) and 
aerosolisation (Kaialy and Nokhodchi, 2013b), were deeply influenced by the material’s surface 
properties. The electrostatic charge characteristics of pharmaceutical powders have been 
correlated with surface energy measurements obtained using inverse gas chromatography (Jallo 
and Dave, 2015). Powders with  higher specific surface areas (Murtomaa et al., 2004a) and 
higher surface free energies (Traini et al., 2012) demonstrated higher levels of netcharge. 
Particle surface roughness affects the overall charge-transfer because it affects the 
interparticle and particle–surface contact areas (Vladykina et al., 1985). Theoretically, for 
insulator materials, electrostatic charges concentrate on the peaks of surface asperities leading to 
dissimilar charge distribution across the particle surface, i.e., regions with higher surface 
roughness would have higher energy states (Hogue et al., 2004; Kwok et al., 2005). This was 
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evident in the study by (Kwek et al., 2013) who showed the rough mannitol particles generated 
by spray drying to exhibit a higher surface potential in comparison to the smooth particles (‒ 5.9 
kV/m2 versus 1.4 kV/m2). Such difference could be related to other physicochemical properties 
that varied along surface roughness. The rough mannitol particles showed a smaller mean 
diameter (2.7 µm versus 4.6 µm), a higher surface area (2.54 m2g-1 versus 1.21 m2g-1), a higher 
dispersive surface free energy (56.2 mJ.m-2 versus 34.6 mJ.m-2), and an increased moisture 
sorption compared to the smooth particles. Rough mannitol particles were also prepared under 
higher atomising rates (670 Nl.min-1 versus 357 Nl.min-1) and lower inlet temperatures (145 ºC 
versus 170 ºC) compared to the smooth particles. With such complex interplay among 
physicochemical properties and operational factors, our understanding of the effect of surface 
roughness on electrostatics is far from complete, thus more controlled studies are needed in the 
future.  
3.2.5. Polymorphic form  
Polymorphism is the ability of a particle to exist in more than one form. About one-third of all 
drugs displays polymorphism (Henck et al., 1997). The polymorphic form of a material could 
influence its charging behaviour. This is because different solid forms (e.g., crystalline and 
amorphous) of the same pharmaceutical material may show different charge-transfer behaviours 
(Murtomaa et al., 2004a), attributed to their different crystal packing, surface energies, surface 
work functions, and moisture contents. However, the influence of crystallinity on the charging 
properties is not consistent throughout the literature. (Carter et al., 1992) showed the spray-
dried amorphous lactose to have lower levels of electrostatic charge than the fractionated 
crystalline lactose. In contrast, other studies reported an increase in electrostatic charging 
with increasing amorphous content. For example, (Kwok and Chan, 2008) showed amorphous 
(spherical-shaped) salbutamol sulphate (SS) particles to be more charged than the crystalline 
(plate-like shaped) particles. (Murtomaa et al., 2002) evaluated the influence of crystallinity on 
the tribocharging of lactose powders. The charging behaviour of lactose (d50%: 45 μm to 55 
μm) was shown to decrease with increasing crystallinity. (Murtomaa et al., 2004a) also showed 
that lactose particles with a higher amorphous content carried a higher level of electrostatic 
charge. In the same line, (Shekunov et al., 2002) showed the supercritical fluid conditioned 
salmeterol xinafoate to have a higher crystallinity and reduced level of electrostatic charge 
compared to both granulated and micronised powders. These inconsistencies show that other, 
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interrelating parameters must be in play. For example, particle size and shape distributions 
were not controlled in the latter studies. This was verified in a study by (Bennett et al., 1999) 
who showed that the level of electrostatic charge within two-component mixes of spray dried and 
crystalline lactose depends on particle size distribution of the resultant mix, i.e., charging increase 
with decreasing fine particulate content. In the study performed by (Murtomaa et al., 2004a), 
amorphous lactose particles were less homogeneous in shape and had wider size distributions in 
comparison to crystalline lactose particles. Furthermore, the influence of crystallinity on the 
charging behaviour is further complicated by their differences in moisture content. Amorphous 
and ‘partial amorphous’ particles usually have higher moisture contents than the crystalline 
particles (Figure 1), due to their less dense structure and increased ‘free’ volume into which water 
vapour could penetrate more easily (Ahlneck and Zografi, 1990). To eliminate this ambiguity, 
(Wong et al., 2014) conducted a more controlled study to evaluate the effect of crystallinity on 
the electrostatic charge properties of inhalable SS particles with a spherical shape and well-
defined size distribution (d50%: 2.71 µm to 2.82 µm, span: 1.79 to 1.86). Amorphous SS was 
shown to have less consistent charging behaviour in comparison to crystalline SS.  
The charge distribution on a particle surface is also influenced by crystallinity. Charge 
distribution is expected to occur faster on the surface of amorphous particles than on the surface 
of crystalline particles, because molecules’ mobility is higher for an amorphous material in 
comparison to a crystal lattice. Therefore, electrical charges may distribute homogeneously on 
the surface of spherical amorphous particles whereas most charges may concentrate on the tips 
and edges of crystalline irregular particles (Zeng et al., 2001) (Figure 3). 
3.3. Hygroscopicity and relative humidity 
Moisture uptake is related to relative humidity (RH) of the environment (an external factor), as 
well as, both the chemical (e.g., hydrophilicity and hydrophobicity) and physical (e.g., 
powder specific surface area and particle anomeric composition) properties (Van Campen et 
al., 1983). The role of the specific surface area in moisture sorption is particularly relevant to 
‘adsorption’ and to a lesser extent to ‘absorption’. For absorption, it only increases the rate of 
moisture uptake. The risk of water sorption on the stability of pharmaceutical powders has been 
described in depth elsewhere (Coelho and Harnby, 1978; Hickey and Martonen, 1993; Maggi et 
al., 1999).  
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Moisture sorption behaviour is the ability of a hygroscopic material to absorb or release water 
vapour from or into the air until an equilibrium state is reached. The particle hygroscopicity and 
the environmental RH are both important factors influencing powder charge because moisture 
has a considerable effect on the electrical conductivity of particle surface (Zhu et al., 2007). The 
effect of RH on particle electrostatic charging is complex and depends on many factors (Kwok 
and Chan, 2008). Most studies showed the netcharge to decrease with the increase in RH, 
regardless of the contact surface (Elajnaf et al., 2006; Rowley and Mackin, 2003). However, such 
effect depends on the material’s hygroscopicity (which is an intrinsic property) and moisture 
sorption behaviour (which is a function of hygroscopicity as well as of physicochemical 
properties such as size distribution, shape distribution, porosity, solid-state, etc.) (Kwok and 
Chan, 2008). A decreased surface resistivity and a consequent charge dissipation have been 
suggested in the case of a higher RH (Paasi et al., 2001). In addition, by increasing the RH, the 
absolute amount of water in the air (g/m3) (and thus the air conductivity) increases leading to an 
enforced gas discharge (Karner and Urbanetz, 2011). In the context of aerosolisation 
performance, (Yurteri et al., 2002) suggested that there is an optimal RH, at which a balance 
between electrostatic and capillary forces exists, leading to minimal cohesive forces and thus an 
improved DPI dispersion behaviour. 
3.4. Pharmaceutical processing 
3.4.1. Milling 
Milling is an important unit operation that is employed frequently in the pharmaceutical industry 
for the production of pharmaceuticals in the respirable size. In general, particle charging 
increases with the level of energy introduced to solid particles (Bailey, 1993). Milled particles 
usually exhibit high levels of electrostatic charge (ranging from 0.1 nC/g to 100 nC/g as given in 
the British Standard (Steele, 2001)), potentially leading to an increased interparticle cohesive 
forces and a consequent poor product performance (Brodka-Pfeiffer et al., 2003; Rasenack et al., 
2004). Such charging generated on mechanically milled powders is induced by the interparticle 
and particle-wall collisions and sliding with different surfaces during milling (Feeley et al., 1998). 
Additionally, milling involves size reduction and thereby a milled powder typically contains an 
increased proportion of fine particulates compared to an unmilled powder (Figure 1). The effect 
of particle size distribution on charging characteristics is discussed previously (chapter 3.2.2.). 
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3.4.2. Spray drying  
Spray drying is a drying technique in which a dry powder is produced by evaporating the liquid 
from the atomised feed when it mixes with a drying hot gas medium (Vehring, 2008). The 
separation of the product in the spray dryer usually takes place in the cyclone; however, other 
separation equipment such as electrostatic precipitators could be used (Patel et al., 2009). Several 
studies evaluated the tribocharging of spray dried products (Carter et al., 1998a; Cassidy et al., 
2000; Murtomaa et al., 2002); nevertheless, the location where the static electrification takes 
place during spray drying was not clear. (Murtomaa et al., 2004b) concluded that spray drying 
generates a complex bipolar charging behaviour of the produced particles. It was argued that the 
static charge could be generated during the spray drying process in different parts of the spray 
dryer in different mechanisms: in the feed pipe (double layer charging), in the spray nozzle 
(double layer or induction charging), and at the walls of the spray cylinder and the cyclone 
chamber (contact and frictional charging). In general, spray drying produces particles with 
relatively high levels of electrical charge since the solutions prepared for drying are aerosolised 
into small droplets, which are next dried in a hot-air cyclone. Additionally, the differences in 
physicochemical properties (e.g., polymorphic form, size distribution, porosity, and surface 
properties) contribute to the considerable differences in charging properties between the spray 
dried and the parent particles (Carter et al., 1998a; Cassidy et al., 2000; Murtomaa et al., 2002) 
(Figure 1). 
3.4.3. Sieving 
Sieving (size fractionation) is a pharmaceutical process by which particles are passed through a 
series of sieves with progressively smaller square mesh sizes whereupon the particles are 
weighed and thereafter classified into size-fractions based on which mesh size they did not pass 
through. Sieving is a rough method in determining particle size. This is because sieving 
(especially mechanical sieving) cannot effectively separate all the fine particulates adhering to 
the surface of large particles (Kaialy and Nokhodchi, 2016; Kaialy et al., 2012b). Alternatively to 
mechanical sieving, the removal of fine particulates from the surface of coarse carrier particles 
has been achieved using air-jet sieving (Kaialy et al., 2012a; Kaialy et al., 2012b; Tee et al., 
2000), air washing of the particles held on the top of a sieve (Zeng et al., 1999), and wet 
decantation (Islam et al., 2004). 
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In drug–carrier DPI formulations, the carrier particles are usually sieved into a size range of 63 
µm to 90 µm or 70 µm to 100 µm (Kaialy et al., 2011; Kaialy et al., 2012a; Steckel and Bolzen, 
2004). It is also common to subject the drug particles to sieving to remove any large drug 
agglomerates before mixing with coarse carrier particles. (Bechtold-Peters et al., 2005) showed 
the sieved micronised fenoterol drug particles to have greater electrostatic charge compared to 
the unsieved drug. Such charge acquisition of the sieved drug was subsequently reduced by 
surface treatment with sorbitan trioleate, leading to improved inhalation properties of fenoterol 
powders. (Noras, 2008) introduced a stackable Faraday pail by which the charging behaviour 
during sieving could be assessed.  
In general, sieving produces lower levels of charge than other industrial processes such as 
micronisation and pneumatic conveying (Gibson, 1997). One reason for this is that the sieving 
process produces particles of a lower surface area-to-mass ratio in comparison to micronisation 
processes such as milling. For example, in contrast to milling, a significant particle size reduction 
is not typically involved during sieving (Figure 1). Mechanical sieving is typically not suitable 
for particles <38 µm due to particle cohesiveness. Additionally, several process parameters 
(process time, the number of particle-particle collisions per unit time, etc.) could be involved in 
the difference in effect between the unit operations mentioned. For example, the amount of work 
done on a sieved powder is relatively less than that done on a milled powder. (Telko et al., 2007) 
evaluated the influence of several formulation parameters on the charging behaviour of SS–
lactose binary mixtures. The propensity of negative charging was shown to increase when sieved 
lactose was used, whereas the use of milled lactose promoted positive charging. One reason for 
such variation in charge sign is that the sieved lactose (Respitose® SV003; d50%[d10% to d90%] = 
60[30 to 100] µm) contains a lower proportion of fine particulates and different particle 
morphologies in comparison to the milled lactose (Respitose® ML001; d50%[d10% to d90%]: 55[4 to 
170] µm), which indicates the need for more controlled investigations in the future.  
3.5. Storage 
Over time, the charge accumulated on a powder surface will decay (dissipate) to a certain limit 
(Malave-Lopez and Peleg, 1985). Charge decay is a complex phenomenon that has been 
measured by different techniques (Paasi et al., 2001). The timescale for electrostatic charge decay 
is an important factor. For example, there will be a higher probability of a considerable charge 
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build-up on a material when charge decay occurs slowly. The charge decay rate is a measure of 
the rate at which the electrostatic charge present on the surface of a material can migrate away 
(Chubb, 2002). The charge decay rate depends on many factors, including the material’s 
electrical resistivity, the resistivity of the other material on contact, RH of the surrounding air, 
and the hold time (Bailey, 1993; Sharma et al., 2001a). The lower the material electron 
conductivity the longer the time needed for charge decay. A powder in contact with a conductive 
material will dissipate the charge quicker than the same powder in contact with an insulator. 
Since moisture adsorption makes a material more conductive, the charge decay rate increases 
with increasing RH due to a concurrent decrease in surface resistivity (Paasi et al., 2001). (Engers 
et al., 2006) showed the hold time (the time passed between the end of processing and dispensing 
the sample into the Faraday cup for charge measurement) as the most effective option of 
dissipating charge following the blending of eight different common pharmaceuticals in a 
stainless steel low-shear blender. (Kulvanich and Stewart, 1988) also showed a significant 
decrease in the adhesive forces of several model drug particles to the surfaces of hypromellose-
coated glass beads during storage over 23 days due to charge decay.  
Most pharmaceuticals are insulating organic materials (resistivities above 1013 Ωm) (Byron et al., 
1997; Carter et al., 1998b), thus their charge relaxation times would broadly range from minutes 
to hours (Bailey, 1984). (Elajnaf et al., 2007) evaluated the charge decay characteristics of two 
drugs (SS (d50% = 1.7 µm) and ipratropium bromide monohydrate (d50% = 1.7 µm)) and one 
carrier (α‒lactose monohydrate, 63 µm to 90 μm) commonly used in DPI systems under different 
humidity conditions (RH = 0% to 86%). The decay behaviour results of the three materials 
showed ipratropium bromide to have the highest decay rate, whereas SS had the lowest. The 
decay rates of all materials were shown to increase with increasing the RH from 0% to 86%. The 
total drug–excipient adhesion forces were shown to decrease with the decay of electrostatic 
charge during storage. In another study, (Staniforth and Rees, 1982) showed that the electrical 
charges on lactose surface decay within a few minutes. This agreed with a study by (Carter et al., 
1998b) who showed a rapid charge decay for lactose, whereas micronised SS retained substantial 
charge after 2 h. (Traini et al., 2012) showed the fine particle fraction (FPF) of SS aerosolised 
from the CyclohalerTM (at a flow rate of 60 L/min) to increase slightly after storage for 2–weeks 
at a RH of 45% and 20 ºC, although such increase was not statistically significant. This was 
explained by charge relaxation during storage, with a consequent increase in aerosol performance. 
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After 6 months of storage at a RH of 32% ± 2% and 21 ºC ± 1 ºC, (Murtomaa et al., 2004a) 
showed the TaifunTM inhaler to result in minimal changes in netcharge in comparison to 
ClickhalerTM, attributable to the desiccant capsule in the TaifunTM inhaler device which can 
protect the formulation powder from environmental conditions during storage. 
4. Electrostatics in inhalation powders 
There has been an increased interest over the last few years in the measuring of electrostatic 
charge of pharmaceutical aerosols. Such measurements constitute an area of an important step in 
the development of pharmaceutical aerosols (Ehara et al., 1996; Emets et al., 1991; Flagan, 1998). 
4.1. Drugs, carriers and contact surfaces 
In the static state (i.e., before aerosolisation), the charge level and sign of drug–carrier inhalation 
powders was shown to be influenced by the type of drug, carrier and contact surface, as well as 
drug–carrier interparticle interactions. Powders in the respirable size (≤ 5 µm in aerodynamic 
diameters) have large specific surface areas (several square meters per gram) and therefore 
respirable drug particles can carry large levels of charges (Mehrani et al., 2007) (Grosvenor and 
Staniforth, 1996; Peart, 2001a). A summary of the charge series of drugs and excipients 
established in the literature is provided elsewhere (Wong et al., 2013). In general, excipients tend 
to show lower levels of charge than drugs (Šupuk et al., 2012). In contrast to SS drug that carried 
an electronegative charge (Kaialy and Nokhodchi, 2016), several common carriers used in DPI 
systems such as lactose, glucose (Murtomaa and Laine, 2000) and mannitol (Kaialy et al., 2014) 
demonstrated an electropositive charge. The electrostatic charge of carrier particles (e.g., lactose, 
mannitol, glucose, etc.) could have a considerable influence on the aerosolisation behaviour of 
DPIs (Bennett et al., 1999). For example, (Mackin et al., 1997) showed the electrostatic charging 
of lactose (63 µm to 90 µm) and micronised salmeterol xinafoate before DPI–filling to reduce 
the respirable fraction of micronised salmeterol xinafoate aerosolised from the Diskhaler® at 60 
L/min.  
Typical drug–carrier DPI formulations consist of at least two different components (i.e., a drug 
and a carrier) which could result in complicated bipolar charging (Murtomaa and Laine, 2000). 
Following the addition of SS drug particles to mannitol carrier particles, drug–carrier DPI 
formulations demonstrated a higher netcharge than the carrier (Karner and Urbanetz, 2013). 
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(Elajnaf et al., 2006) studied the role of tribocharging in interparticle interactions between 
micronised SS and ipratropium bromide with lactose (α–lactose monohydrate, 63 μm to 90 μm) 
during mixing in different blending vessels. The charge of the drugs and the lactose carrier 
particles were shown to change following blending. SS acquired a high electronegative netcharge 
in contact with stainless steel, but an electropositive netcharge in contact with polymeric vessels 
(Elajnaf et al., 2006). Since lactose usually shows an electropositive charge behaviour (Kaialy 
and Nokhodchi, 2016; Palonen and Murtomaa, 2003), it could be assumed that the use of a metal 
equipment would encourage the formation of a SS–lactose adhesive mixture, whereas the use of 
plastic inhalers may promote SS–lactose detachment during aerosolisation (Peart, 2001b, 1996).  
4.2. Dry powder inhalers 
DPIs comprise a pharmaceutical dosage form of increasing popularity with attractive features 
such as the provision of a propellant-free means of drug delivery and such formulations have 
rapidly increased in number (Smith and Parry-Billings, 2003). In general, DPI performance is 
affected by three main factors: the design of the inhaler device (Dalby et al., 1996), inhaler 
powder formulation properties (with respect to the physicochemical properties of the drug and the 
carrier) (Kaialy and Nokhodchi, 2012; Kaialy et al., 2015; Kaialy et al., 2012c; Timsina et al., 
1994), and patient airflow and inhalation manoeuvre (Chan, 2006). The DPI performance is most 
importantly affected by particle–particle interactions (Guchardi et al., 2008). Some of the most 
attractive methods to improve DPI performance include the use of engineered drug (Dhumal et al., 
2009; Xu et al., 2012) and/or engineered carrier (Kaialy et al., 2015, 2010; 2012b) particles.  
Drug particles usually separate from the larger carrier surface particles, or both the drug and 
carrier separate from the inhaler device, resulting in a netcharge on the particles (Telko et al., 
2007). Indeed, the complete understanding of the relationships between electrostatic charge and 
DPI performance is still challenging due to the complexity of DPI systems and the heterogeneous 
nature of the particles used. Nevertheless, it could be anticipated that high resistance DPI devices 
(such as the Handihaler®, Easyhaler® and Turbuhaler®) generate higher levels of electrostatic 
charge in comparison to low resistance DPI devices (such as the Rotahaler®, Diskus® and 
Cyclohaler®), due to a higher shearing and consequently a higher particle tribocharging (Telko 
et al., 2007). (Byron et al., 1997) showed that the estimated charge level of respirable budesonide 
following aerosolisation from the Turbohaler® is high enough to affect deposition. Battery-
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operated DPIs have also been introduced, in which powder dispersion is enhanced using 
electrostatic technologies (Nilsson, 2000; Sun et al., 1999). (Ali et al., 2008) studied the charging 
behaviour of several commercially available DPIs (the Spiriva Handihaler®, Pulmicort 
Turbuhaler ® and Advair Diskus®) in real time using the electrical single particle aerodynamic 
relaxation time (E-SPART). However, the data interpretation is limited because the inhalers 
studied contain different formulations (i.e., different drug-excipient adhesive mixtures), thus 
more controlled studies are justified in the future. 
4.3. Influence of powder charge on DPI performance 
4.3.1. Blending and drug content homogeneity  
Blending is an energy consuming process that shuffles individual particles, small particle groups, 
and large particle groups of two or more different portions of a material to produce a distribution 
of particles with a desired level of uniformity in the final mixture. Blending of dry 
pharmaceutical solids is an important step in the production of carrier-based DPI formulations 
(Saleem et al., 2008). Segregation and agglomeration are two main problems frequently faced in 
powder-mixing processes, resulting in drug content homogeneity problems (Cartilier and Moës, 
1989). Recently, there has been increased attention towards the tribocharging phenomenon 
during powder blending processes (Karner and Urbanetz, 2012; Zhu et al., 2007). The control of 
powder charge is important to maximise mixing efficiency (Engers et al., 2007). This is because 
the electrostatic forces generated during powder mixing lead to an accumulated charge, which in 
turn can cause adhesion and/or agglomeration resulting in processing difficulties (Gibson, 1997; 
Muzzio and Alexander, 2005). Electrostatic forces have been shown to affect the number of 
agglomerates formed during mixing of powder systems. The decrease of electrostatic charges 
generated during mixing was shown to lead to a decrease in the intensity of interparticle 
attraction forces, leading to a reduced agglomeration tendency (Lachiver et al., 2006). 
Powder mixing is broadly classified as randomised (Buslik, 1973; Lacey, 1997) and ordered 
mixing (Hersey, 1975), but there are good arguments to reject the term 'ordered' and to speak of 
'adhesive' instead (Staniforth, 1987). In randomised mixtures, the mixing process is often 
performed with (multi-component) mixtures of particles having approximately the same size 
distribution (to avoid segregation) in which gravitational forces exceed the interparticulate 
forces. Adhesive mixtures are formed when small drug particles are mixed with large carrier 
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particles where they become tenaciously attached to the carrier surface, and so they would 
exhibit great resistance to being dislodged (Staniforth, 1987). In adhesive mixtures, the attractive 
forces holding the particles to the adsorption site on the carrier surface are greater than the 
gravitational forces. Recently, it was proposed that the activity of surface sites on carriers for 
dry powder inhalation  is a result of the interplay of the physicochemical properties of the 
carrier surface, as well as relevant formulation and dispersion conditions (Grasmeijer et al., 
2014). Initially, the term 'ordered mixture' (introduced by (Hersey, 1975) to describe a new 
mixing mechanism) became popular to describe mixtures with a degree of homogeneity 
higher than theoretically possible on the basis of  homogeneity equations derived 
(statistically) by (e.g.) (Buslik, 1973) and (Lacey, 1997). Later, it became generally 
acknowledged that ordered mixing is a concept and that such mixtures could be highly 
inhomogeneous too. Nevertheless, due to the high interaction forces between particles 
relative to the gravitational forces, adhesive mixtures are generally less prone to segregation 
than random mixtures. A real risk of adhesive mixtures is the loss of active material (mostly 
present in low concentrations) to the walls of the process equipment. 
Fine drug particles adhere to the surface of the coarse carrier particles by van der Waals, capillary, 
electrostatic or mechanical forces. Although van der Waals forces are the most important 
interparticle forces between the drug and carrier particles in the case of adhesive mixtures, 
manipulating the electrical properties was used to introduce electrostatic forces between the drug 
and the carrier particles and thereby reducing particle segregation tendency within an adhesive 
mixture (Staniforth and Rees, 1981, 1982). However, the properties of the final mixture depend 
on the type and physicochemical properties of the mixed materials. (Bennett et al., 1999) reported 
that the adhesion of fine lactose particulates (<10 µm) to the inner surfaces of the charging 
instrument (stainless steel) can reduce the frequency of drug particle-surface interactions, leading 
to an increased drug–drug interparticulate interactions. Such increased interactions may be 
responsible for generating a heterogeneous bipolar system and thereby influencing the final 
netcharge. 
The uniformity of blending is an essential factor for the uniformity of consequent dosing. During 
blending of the fine particulates with coarse particles, a competition is believed to take place 
between the cohesive (drug–drug) and the adhesive (drug–carrier) forces within a formulation 
(Dickhoff et al., 2002). The outcome of the resultant equilibrium was shown to be favoured 
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towards adhesion in the case of small drug and/or small carrier particles and carrier particles with 
rough surfaces (Staniforth, 1987). To achieve an even distribution of drug particles among the 
carrier particles, the drug–carrier adhesive forces should be stronger than the drug–drug cohesive 
forces. The ratio between the cohesive forces and the adhesive forces, i.e., the Cohesive-
Adhesive Balance (CAB) ratio (Begat et al., 2004a, 2004b), was shown to have a dominant effect 
on the mixing efficiency and the aerosolisation performance of DPI formulations. A stable 
adhesive mixture could be expected when the CAB ratio of a drug–carrier combination is < 1, 
i.e., adhesive drug–carrier forces > cohesive drug–drug forces. In contrast, a less uniform mixture 
is expected when the CAB ratio is > 1, i.e., cohesive drug–drug forces > adhesive drug–carrier 
forces (Begat et al., 2004a, 2004b).  
A reduced mixing efficiency could be anticipated in the case of drug and carrier particles with 
similar charge sign (both electropositive or both electronegative) due to an expected reduced 
drug–carrier adhesion (Zeng et al., 2001). In contrast, a stronger drug–carrier adhesion forces and 
therefore a promoted mixing efficiency and an improved drug content homogeneity are expected 
in the case of drug and carrier particles with opposite signs of electrical charges (Lachiver et al., 
2006; Staniforth and Rees, 1981, 1982; Staniforth, 1995). For example, (Pu et al., 2009) showed 
that blends composed of positively charged excipient particles (e.g., lactose) and negatively 
charged drug particles (e.g., SS) demonstrated an improved drug content homogeneity due to a 
strengthened drug–carrier interparticle adhesion. 
The mixing ratio of at least two different materials within a mixture is another factor that further 
complicates the tribocharging behaviour of powder mixture systems (Engers et al., 2007, 2006). 
Some reports examined the tribocharging behaviour of lactose in binary mixtures. When blended 
with SS, (Elajnaf et al., 2006) showed the netcharge of lactose powder to decrease because of 
adhesion to the mixing vessel surface. (Rowley, 2001) showed the electrostatic charge of SS–
lactose binary mixtures to increase with decreasing the concentration of SS.  
Recently, a mechanism governed by the electrostatic force has been proposed to understand the 
blending process of drug and carrier particles in DPI formulations using a discrete element 
method (DEM) (Yang et al., 2015). The number of drug particles adhering to coarse carrier 
particles was shown to decrease with decreasing charge and decreasing the vibrational velocity 
amplitude and frequency in a vibrating container. The difference between long-range and short-
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range adhesive forces resulted in different mixing behaviours. The kinetics of particle charging in 
mixers have been described elsewhere (Zhu et al., 2007). 
The pharmaceutical industry has rigorous regulations for satisfactory content uniformity. The 
efficiency and safety of the final DPI product are considerably influenced by electrostatic charge. 
In general, charged particles could be either attracted to or repulsed to each other, promoting 
powder agglomeration or segregation (Beeckmans et al., 1979), both have a detrimental influence 
on the homogeneity of powder mixtures (Pu et al., 2009). The electrostatic charge could lead to 
less dose homogeneity due to the forming of regions with different densities and flowabilities 
within a powder. Some researchers have shown that powder blends with higher levels of 
netcharge are more cohesive and have increased segregation tendencies (and thus reduced 
physical stabilities) (Staniforth and Rees, 1982). For example, (Pu et al., 2009) investigated the 
process of blending by using lactose (90 µm to 120 µm) as an excipient with caffeine (40 µm to 
90 µm) as a drug after tribocharging with steel and polyamide contact surfaces. A strong 
correlation was established indicating that powders with higher levels of netcharge demonstrate 
poorer drug content homogeneities. This was confirmed by a recent study, which showed the 
coefficient of variation (CV) of SS content within SS–mannitol DPI formulations to increase with 
the increase of mannitol netcharge (Figure 5) (Kaialy et al., 2014). (Pu et al., 2009), (Hao et al., 
2013) and (Kaialy et al., 2014) related the elimination or reduction of electrostatic charges to 
better homogeneity of the formulation blends.  
4.3.2. Aerosolisation behaviour 
In drug–carrier DPI systems, electrostatic forces may have a dominating influence on the 
adhesion, detachment (Staniforth, 1995) and deposition of fine drug particulates (Bailey, 1997). 
Both the static (i.e., before aerosolisation – within the powder bed) and the dynamic (i.e., during 
aerosolisation) electrifications of DPI formulation powders should be considered and understood 
to enhance the performance of DPIs. The electrostatic forces are generally larger than the 
gravitational forces, but smaller than the dispersion forces. Before aerosolisation, both the type 
of materials that constitute the DPI formulation (Carter et al., 1998) (chapter 4.1) and the 
formulation physicochemical characteristics (Peart, 1996) (chapter 3.2) influence the charge 
behaviour of the final DPI dosage form, as discussed previously.  
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Drug and carrier particles generated from DPIs inevitably undergo tribocharging during frequent 
particle–particle physical contacts, particle contacts with the surfaces of the components of the 
inhaler device, and high impact velocities during their use, resulting in charged aerosols. Such 
charging could affect their dosing and aerosolisation performance (Karner and Urbanetz, 2011). 
Tribocharging occurs at this point in time of fluidisation of the powder bed through the inhaler 
device by the inspiratory airflow. In general, the level of charging increases with the energy input 
involved (Bailey, 1993; Šupuk et al., 2012). This has been evident during aerosolisation since 
several reports showed the powder netcharge to increase with increasing the pressure/airflow rate 
employed during aerosolisation (Chow et al., 2008; Hoe et al., 2010, 2009a, 2009b). The 
electrical charging of some pharmaceutical powders was shown to increase at least 100 times 
after aerosolisation induced by a turbulent airflow within an air cyclone. For example, 
(Staniforth and Rees, 1982) showed the absolute amount of netcharge of lactose particles (500 
μm to 710 μm) to increase from 0.63 nC/g following pouring off a glass surface to ‒470.0 nC/g 
subsequent to fluidisation in an earthed brass cyclone. In another study, the electrostatic charges 
of an inhalation grade of coarse lactose (InhaLac® 230, d50%: 70 µm to 110 µm) were shown to 
be considerably higher in level following aerosolisation (from the Rotahaler® at flow rates 
ranging between 30 and 75 L/min) compared to the initial charges of the bulk and capsulated 
lactose (Chow et al., 2008). Therefore, because aerosolisation is more energetic than blending, it 
could be assumed that the initial charges of powders before aerosolisation could be negligible in 
level in comparison to the charges generated during powder dispersion. This explains why, for 
example, the original electrostatic charge levels of mannitol powders (d50% = 3.5 µm) tumbled in 
containers of different materials were inadequate to significantly influence the FPF of SS 
aerosolised from the Aerolizer® at a given flow rate (60 L/min) (Adi et al., 2010). This was also 
in line with a recent study by (Kaialy et al., 2014) who showed that the original electrostatic 
charges of several size-fractions of mannitol (d50%: 45 µm to 122 µm) before aerosolisation had 
no significant effect on the aerosolisation performance of SS from the Aerolizer® at 92 L/min.  
Some reports confirmed that the charging behaviours of aerosolised drug–carrier formulations 
are very different to drug only formulations (Byron et al., 1997). Following the aerosolisation of 
lactose–beclomethasone dipropionate formulation from the Easyhaler™, lactose particles were 
positively charged, whereas the drug particles (mostly) charged negatively (Palonen and 
Murtomaa, 2003). SS particles formulated with lactose were shown to charge negatively when 
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aerosolised from the Dryhaler® (Byron et al., 1997) and the Rotahaler® (Zhu et al., 2008). These 
observations are in line with many studies of micronised SS aerosolised from DPIs (Hoe et al., 
2011; Young et al., 2007). Such results support the argument that drug and carrier particles will 
have a significant tendency to dynamic charge-transfer not only during blending (Elajnaf et al., 
2006) but also during drug–carrier detachment upon aerosolisation (Kwok and Chan, 2009). 
These conclusions were further supported by theoretical and experimental studies which 
demonstrated that pharmaceutical aerosols acquire bipolar charge during aerosolisation (Kulon 
and Balachandran, 2001; Saini et al., 2007). It could be argued that the micronised drug deeply 
influence the charging characteristics of lactose and vice versa. However, evidence to corroborate 
such an explanation was not provided. The opposite charge signs of drug and carrier particles 
generated following aerosolisation could result from the dislodgement of fine drug particle from 
the surface of coarse carrier particles during aerosolisation, and it is expected to discourage 
drug–carrier detachment during aerosolisation (Peart, 2001a, 1996).  
The reviewed literature has shown that the tribocharging of particles during aerosolisation is 
influenced by the interplay between several factors, including the particle physicochemical 
properties (Karner and Urbanetz, 2011), the inhaler type/design, drug/carrier type, the drug load, 
the capsule material and the inhalation flow rate (Byron et al., 1997; Palonen and Murtomaa, 
2003). Furthermore, the influence of these several factors (such as capsule material, inhaler 
device, lactose carrier grade and mixing procedure) on the charging properties of drug–carrier 
DPI formulations were shown to be not strictly additive (Hoe et al., 2010).  
At the clinical level, the electrostatic charge in DPI formulations could cause powder aggregation 
and fluidisation problems. This could result in an increased oropharyngeal drug deposition and 
consequently a reduced bioavailability and increased side effects, especially for corticosteroids 
(Noakes, 2004). The highly charged particles can deposit on the surface of the inhaler device by 
electrical precipitation. Therefore, the reduced bioavailability may also result from high amount 
of drug being retained by the DPI device. This was supported by (Byron et al., 1997) who 
showed the drug particles and the inhaler–mouthpiece to carry opposite charges following 
aerosolisation. In the same line, (Kaialy et al., 2014) showed that SDM carrier particles with 
higher levels of netcharge deposited higher amounts of drug (SS) on the inhaler device, inhaler–
mouthpiece and induction port when aerosolised from the Aerolizer® at 92 L/min.  
25 
 
4.4. Influence of electrostatic charge on aerosol lung deposition 
It has established that the charge of aerosolised particles could influence their deposition profiles 
in the airways (Matsusyama and Yamamoto, 2006; Melandri et al., 1983), thus the electrostatic 
charge of pharmaceutical aerosol particles is a subject for formulation optimisation (Melandri et 
al., 1983). The deposition of charged particles has been extensively studied using computational 
lung models (Hashish et al., 1994; Saini et al., 2004).  
The deposition of aerosolised drug on the respiratory system is ruled by inertial impaction, 
gravitational sedimentation and Brownian diffusion (Gonda, 1991). The deposition may also 
occur by other less important mechanisms, such as electrostatic attraction (for charged particles) 
and interception (for elongated particles). The deposition by electrostatic attraction is small 
(contributing to < 10% of overall deposition) (Lippmann and Schlesinger, 1984; Schlesinger, 
1995). This is because the electrostatic force is inversely related to the square of the distance 
between charged objects (Coulomb’s law, Eq. 1) (Mansur and Mansur, 2011). Electrostatic 
attraction is relatively more relevant for the deposition on the lower airways, especially in the 
alveolar region (Balachandran et al., 1997; Gonda, 2004; Melandri et al., 1983).  
DPI performance could be improved by taking advantage of electrostatic charges present on the 
particles. Several theoretical and experimental studies concluded that particles with higher levels 
of electrostatic charge have a higher probability to deposit on the airway surfaces due to higher 
attractive forces (Chang et al., 2012; Cohen et al., 1998, 1995; Fleming et al., 1996). 
Electrostatic forces are divided into two different categories, i.e., space charge and image charge 
(Virtanen et al., 2001). Space charge refers to interparticle repulsion within the airstream. 
Although space charge has been reported to be more relevant at the upper airways for dense 
aerosol clouds (Yu, 1977), it has a considerably low contribution on the overall particle 
deposition on the upper airway regions in which inertial impaction is the dominant mechanism. 
Image charge is particle–image charge on a surface attraction. Processing and handling of 
powders during manufacture generate tribocharging and/or contact charging (Kulvanich and 
Stewart, 1987). When those charged particles pass through the lining of the respiratory tract 
(which is uncharged but electrically conductive), they induce an opposite image charge on the 
inner surface of the respiratory tract (Melandri et al., 1975). Since the image charge generated is 
of opposite sign to the original charge, a force of attraction to the airway surface is induced 
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accelerating drug deposition in this region (Garcı́a-Hernández et al., 1998; Schlesinger, 1995). 
However, the latter mechanism is a minor contributor to the deposition of drug particles in the 
upper airway region in comparison to inertial impaction (Lippmann and Schlesinger, 1984). 
Particle deposition by image charge is only important in the alveolar airways for low-density 
particles (Koolpiruck et al., 2004). The use of electrostatic principles to improve the efficiency of 
pulmonary drug delivery has been discussed elsewhere (Chang et al., 2012; Koolpiruck et al., 
2004; Wong et al., 2013). 
5. Outlook and future directions 
Most of the previous studies revised above focused on the factors affecting charge one-by-one, 
neglecting the potential interactions between them. Therefore, there is a need for methodological 
evaluations and predictive in silico investigations in the future to evaluate the significance of the 
factors affecting charge as well as the interactions between them. Additionally, there is an 
increased need to separate and measure the bipolar charges (i.e., to discern positively and 
negatively charged particles) of inhalation powders. The novel approach that has been recently 
developed in the Wolfson centre (University of Greenwich, UK) (Hussain et al., 2013) is a 
capable method to study the bipolarity of inhalation powders. This technique will improve the 
understanding of bipolar electrostatic charges to enhance pulmonary drug delivery (Kaialy and 
Nokhodchi, 2016; Kaialy et al., 2014). In time, the control of the effects of electrostatic charging 
in DPI devices is expected to become obligatory, although a systemic control of the charge sign 
and level in inhalation powders by tribocharging has not been reported yet. Additionally, up to 
now, the influence of electrostatic charge of aerosol particles on aerosol performance in human 
subjects has not been reported and therefore the role of electrostatic charge on aerosolisation 
performance is not yet fully ascertained. Finally, there are concerns of the reproducibility of 
electrostatic charge properties, i.e., the electrostatic charge properties measured in the laboratory 
may not be adaptable to the industrial scale.  
6. Conclusions 
Tribocharging is a popular phenomenon in inhalation solids that arises from particle–particle and 
particle–wall collisions. Charge generation phenomena in inhalation powders could be severe. 
The electrostatic charging phenomenon is complex and difficult to study and control. This is 
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because charging of inhalation powders depends on a combination of many physicochemical 
properties as well as the inhaler design and environmental factors, thus our understanding of 
electrostatic charging is not complete.  
The electrostatic charging process is very sensitive to a multitude of factors and thus a slight 
difference in particle physicochemical properties or the measurement principles could lead to 
significant differences in the charge behaviour of inhalation powders. Moreover, in addition to 
interactions, the linkage between variables is a main complicating element in obtaining a 
fundamental understanding of electrostatic charging in adhesive mixtures for inhalation. 
However, the recognition that interactions among charging, formulations, and aerosolisation 
variables are pervasive is an important step towards the understanding of tribocharging of 
inhalation powders. 
Charging during unit operations can cause agglomeration and lead to serious problems of quality 
control. Electrostatic charge has an influence on both particle transport and deposition on the 
respiratory airways due to space and image charge. Therefore, controlling the electrostatic 
charge of inhalation powders is crucial to improving the quality and efficiency of the inhalation 
product. Although the reduction of powder electrostatic charge may improve the future prospects 
of aerosol formulation powders, it is difficult to ascertain the influence of a single factor such as 
charge level/sign on DPI performance due to the complexity of DPI systems. Therefore, a 
substantial work is warranted to investigate the charging properties of drug and carrier particles 
of DPI systems as well as drug–carrier adhesive mixtures. The study of bipolarity in the drug–
carrier inhalation powders could potentially play an important role in the technological advances 
in the design and development of dry powder inhalation formulations in the future. The 
fundamentals of charging as well as the agglomeration, deagglomeration, and deposition 
properties of charged drug and carrier particles have to be the subject of advanced examination.  
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Legends to figures 
Figure 1. Schematic, simplified presentation of some factors (and their inter-relationships) 
having an effect the electrostatic charging of pharmaceutical solids and adhesive mixtures 
for inhalation. 
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Figure 2. Netcharge (nano-coulomb/gram: nC/g, mean ± SD, n = 6) in relation to volume mean 
diameter (●) (mean ± SD, n = 10) and BET specific surface area (■) (mean ± SD, n = 3) of 
different size-fractions of spray dried mannitol, i.e., SDM–A (90 μm to 125 μm), SDM–B (63 μm 
to 90 μm), SDM–C (45 μm to 63 μm) and SDM–D (20 μm to 45 μm) (Source: reproduced from  
with permission from (Kaialy et al., 2014)). 
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Figure 3. Schematic diagram showing theoretical charge distribution on the surface of spherical 
particles and angular particles. 
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Figure 4. Netcharge–to–mass ratio of mannitol particles with comparable particle size (63 μm to 
90 µm) and two distinct shapes, i.e., spherical shape (spray dried mannitol, SDM) (Source: 
reproduced from  with permission from (Kaialy et al., 2014)) and irregular shape (commercial 
mannitol, CM) (unpublished data). 
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Figure 5. Coefficient of variation of salbutamol sulphate (SS) content in relation to netcharge of 
spray dried mannitol for salbutamol sulphate-spray dried mannitol DPI formulations (Source: 
reproduced from  with permission from (Kaialy et al., 2014)). 
 
